Thalamic dysconnectivity in the psychosis risk syndrome and early illness schizophrenia.

clinical high risk for psychosis connectivity first-episode schizophrenia transition aged youth ultra-high risk

Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
10 2022
Historique:
pubmed: 16 3 2021
medline: 22 12 2022
entrez: 15 3 2021
Statut: ppublish

Résumé

Schizophrenia (SZ) is associated with thalamic dysconnectivity. Compared to healthy controls (HCs), individuals with SZ have hyperconnectivity with sensory regions, and hypoconnectivity with cerebellar, thalamic, and prefrontal regions. Despite replication of this pattern in chronically ill individuals, less is known about when these abnormalities emerge in the illness course and if they are present prior to illness onset. Resting-state functional magnetic resonance imaging data were collected from psychosis risk syndrome (PRS) youth ( Significant effects of group were observed in left and right middle temporal regions, left and right superior temporal regions, left cerebellum, and bilateral thalamus. Compared to HCs, ESZ demonstrated hyperconnectivity to all temporal lobe regions and reduced connectivity with cerebellar, anterior cingulate, and thalamic regions. Compared to HCs, PRS demonstrated hyperconnectivity with the left and right middle temporal regions, and hypoconnectivity with the cerebellar and other thalamic regions. Compared to PRS participants, ESZ participants were hyperconnected to temporal regions, but did not differ from PRS in hypoconnectivity with cerebellar and thalamic regions. Thalamic dysconnectivity was unrelated to positive symptom severity in ESZ or PRS groups. PRS individuals demonstrated an intermediate level of thalamic dysconnectivity, whereas ESZ showed a pattern consistent with prior observations in chronic samples. These cross-sectional findings suggest that thalamic dysconnectivity may occur prior to illness onset and become more pronounced in early illness stages.

Sections du résumé

BACKGROUND
Schizophrenia (SZ) is associated with thalamic dysconnectivity. Compared to healthy controls (HCs), individuals with SZ have hyperconnectivity with sensory regions, and hypoconnectivity with cerebellar, thalamic, and prefrontal regions. Despite replication of this pattern in chronically ill individuals, less is known about when these abnormalities emerge in the illness course and if they are present prior to illness onset.
METHODS
Resting-state functional magnetic resonance imaging data were collected from psychosis risk syndrome (PRS) youth (
RESULTS
Significant effects of group were observed in left and right middle temporal regions, left and right superior temporal regions, left cerebellum, and bilateral thalamus. Compared to HCs, ESZ demonstrated hyperconnectivity to all temporal lobe regions and reduced connectivity with cerebellar, anterior cingulate, and thalamic regions. Compared to HCs, PRS demonstrated hyperconnectivity with the left and right middle temporal regions, and hypoconnectivity with the cerebellar and other thalamic regions. Compared to PRS participants, ESZ participants were hyperconnected to temporal regions, but did not differ from PRS in hypoconnectivity with cerebellar and thalamic regions. Thalamic dysconnectivity was unrelated to positive symptom severity in ESZ or PRS groups.
CONCLUSIONS
PRS individuals demonstrated an intermediate level of thalamic dysconnectivity, whereas ESZ showed a pattern consistent with prior observations in chronic samples. These cross-sectional findings suggest that thalamic dysconnectivity may occur prior to illness onset and become more pronounced in early illness stages.

Identifiants

pubmed: 33719985
doi: 10.1017/S0033291720004882
pii: S0033291720004882
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2767-2775

Auteurs

Susanna L Fryer (SL)

Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.
San Francisco VA Healthcare System, San Francisco, CA, USA.

Jamie M Ferri (JM)

San Francisco VA Healthcare System, San Francisco, CA, USA.

Brian J Roach (BJ)

San Francisco VA Healthcare System, San Francisco, CA, USA.

Rachel L Loewy (RL)

Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.

Barbara K Stuart (BK)

Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.

Alan Anticevic (A)

Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Department of Psychology, Yale University, New Haven, CT, USA.

Judith M Ford (JM)

Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.
San Francisco VA Healthcare System, San Francisco, CA, USA.

Daniel H Mathalon (DH)

Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.
San Francisco VA Healthcare System, San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH